Press Releases April 24, 2026 07:13 AM

KE Holdings Inc. Files Its Annual Report on Form 20-F

KE Holdings Inc. files its 2025 annual report on Form 20-F with the SEC

By Derek Hwang
Share
Twitter Reddit Facebook LinkedIn
BEKE

KE Holdings Inc., a leading integrated platform for housing transactions and services in China, announced the filing of its annual report on Form 20-F for fiscal year ended December 31, 2025. The report is available on the company’s investor relations website and can be requested in hard copy by shareholders and ADS holders.

KE Holdings Inc. Files Its Annual Report on Form 20-F
BEKE
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • KE Holdings is a leading online and offline housing transaction and services platform in China, operating the Lianjia brand and Beike platform.
  • The company filed its annual report on Form 20-F with the U.S. SEC, covering fiscal year 2025.
  • KE Holdings provides a variety of housing related services including sales, rentals, renovation, and furnishing.
  • The company’s operations impact the real estate, online services, and home improvement sectors, with potential influences on U.S. and Chinese equity markets.

BEIJING, April 24, 2026 (GLOBE NEWSWIRE) -- KE Holdings Inc. (“Beike” or the “Company”) (NYSE: BEKE and HKEX: 2423), a leading integrated online and offline platform for housing transactions and services, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission on April 24, 2026. The annual report can be accessed on the Company’s investor relations website at https://investors.ke.com.

The Company will provide a hard copy of its annual report containing the audited consolidated financial statements, free of charge, to its shareholders and ADS holders upon request. Requests should be directed to the Company’s Investor Relations Department at ir@ke.com.

About KE Holdings Inc.

KE Holdings Inc. is a leading integrated online and offline platform for housing transactions and services. The Company is a pioneer in building infrastructure and standards to reinvent how service providers and customers efficiently navigate and complete housing transactions and services in China, ranging from existing and new home sales, home rentals, to home renovation and furnishing, and other services. The Company owns and operates Lianjia, China’s leading real estate brokerage brand and an integral part of its Beike platform. With more than 24 years of operating experience through Lianjia since its inception in 2001, the Company believes the success and proven track record of Lianjia pave the way for it to build its infrastructure and standards and drive the rapid and sustainable growth of Beike.

For investor and media inquiries, please contact:

In China:
KE Holdings Inc.
Investor Relations
Siting Li
E-mail: ir@ke.com 

Piacente Financial Communications
Jenny Cai
Tel: +86-10-6508-0677
E-mail: ke@tpg-ir.com 

In the United States:
Piacente Financial Communications
Brandi Piacente
Tel: +1-212-481-2050
E-mail: ke@tpg-ir.com

Source: KE Holdings Inc. 


Risks

  • GEOPOLITICAL RISKS: As a China-based company listed on U.S. and Hong Kong exchanges, it could face regulatory and geopolitical uncertainties affecting cross-border trade and investment.
  • MARKET COMPETITION: The online and offline housing services market in China is competitive, posing risks to market share and profitability.
  • DEPENDENCE ON CHINESE REAL ESTATE MARKET: The company’s performance is sensitive to fluctuations in China’s real estate sector, including regulatory changes and economic cycles, which could impact revenues and growth.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026